Asset profile
Atezolizumab
Monoclonal antibody
Approvedregulatory verdict
Evidence outlook
Approved: Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
71 competitors in this universe: 10 direct rivals (same mechanism and indication), 1 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Atezolizumab: this drug | Approved | Monoclonal antibody | PD-L1 | ||
| Durvalumab | Approved | Monoclonal antibody | PD-L1 | ||
| Tecentriq Hybreza (atezolizumab And Hyaluronidase-Tqjs) | Approved | Monoclonal antibody | PD-L1 | ||
| Adebrelimab | Phase 3 | Monoclonal antibody | PD-L1 | ||
| CS1001 Monoclonal Antibody | Phase 3 | Monoclonal antibody | PD-L1 | ||
| Envafolimab | Phase 3 | Monoclonal antibody | PD-L1 | ||
| KL-A167 | Phase 3 | Monoclonal antibody | PD-L1 | ||
| PF-08046054 | Phase 3 | Antibody–drug conjugate | PD-L1 | ||
| HLX43 | Phase 2/3 | Antibody–drug conjugate | PD-L1 | ||
| 177Lu-RAD204 | Phase 1 | Radiopharmaceutical | PD-L1 | ||
| BPI-371153 | Phase 1 | Small molecule | PD-L1 | ||
| IBC-Ab002 | Phase 1 | Monoclonal antibody | PD-L1 | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET |
…and 56 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
vs Durvalumab · Non-Small Cell Lung Cancervs Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) · Non-Small Cell Lung Cancervs CS1001 Monoclonal Antibody · Non-Small Cell Lung Cancervs Envafolimab · Non-Small Cell Lung Cancervs Adebrelimab · Non-Small Cell Lung Cancervs KL-A167 · Non-Small Cell Lung Cancer
4 further head-to-head pairs are tracked; the rosters on each shared mechanism and indication page list every rival in the race.
Upcoming events
(216 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (34)
October 2026 (6)
Phase 3Unresectable Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2026-10-14 · NCT04770896 · CT.gov ↗
What to watch
Phase 1/2Non-Hodgkins LymphomaActive not recruiting
Est. primary completion 2026-10-16 · NCT03533283 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-10-27 · NCT06789757 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorRecruiting
Est. primary completion 2026-10-30 · NCT06302426 · CT.gov ↗
What to watch
Phase 2Metastatic Alveolar Soft Part Sarcoma, Unresectable Alveolar Soft Part SarcomaActive not recruiting
Est. primary completion 2026-10-31 · NCT03141684 · CT.gov ↗
What to watch
Phase 2Stomach Cancer, Gastro Esophageal Junction CancerActive not recruiting
Est. primary completion 2026-10-31 · NCT03448835 · CT.gov ↗
What to watch
November 2026 (7)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-11 · NCT04958811 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma, Oral Cavity Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2026-11-01 · NCT05681039 · CT.gov ↗
What to watch
Phase 1Pancreatic CancerActive not recruiting
Est. primary completion 2026-11-11 · NCT04161755 · CT.gov ↗
What to watch
Phase 1Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid NeoplasmActive not recruiting
Est. primary completion 2026-11-21 · NCT02862275 · CT.gov ↗
What to watch
Phase 2Advanced Cancer, Solid Tumor, Haematological MalignancyRecruiting
Est. primary completion 2026-11-25 · NCT05159245 · CT.gov ↗
What to watch
Phase 1Recurrent GlioblastomaRecruiting
Est. primary completion 2026-11-27 · NCT07538128 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-11-30 · NCT04302025 · CT.gov ↗
What to watch
December 2026 (21)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT04691817 · CT.gov ↗
What to watch
Phase 1/2Bile Duct Cancer, Gall Bladder Cancer, Breast Cancer, Neuroendocrine Tumors, Ovarian Cancer, Pancreatic Adenocarcinoma …Recruiting
Est. primary completion 2026-12 · NCT05000294 · CT.gov ↗
What to watch
Phase 1/2Bladder Cancer, Metastatic Bladder Cancer, Urothelial CarcinomaActive not recruiting
Est. primary completion 2026-12 · NCT02989584 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Carcinoma of Lung, TNM Stage 4Active not recruiting
Est. primary completion 2026-12 · NCT03786692 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12 · NCT03915678 · CT.gov ↗
What to watch
Phase 2HER2-positive Breast CancerActive not recruiting
Est. primary completion 2026-12 · NCT03125928 · CT.gov ↗
What to watch
Phase 3Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma, Hepatocellular Carcinoma …Recruiting
Est. primary completion 2026-12 · NCT05482516 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12-01 · NCT05825625 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2026-12-01 · NCT07192185 · CT.gov ↗
What to watch
Phase 1/2Relapsed or Refractory Hodgkin's LymphomaActive not recruiting
Est. primary completion 2026-12-15 · NCT05300282 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast CancerRecruiting
Est. primary completion 2026-12-15 · NCT06690840 · CT.gov ↗
What to watch
Phase 2Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-15 · NCT06771518 · CT.gov ↗
What to watch
Phase 3Invasive Breast CancerActive not recruiting
Est. primary completion 2026-12-15 · NCT03595592 · CT.gov ↗
What to watch
Phase 2Oropharynx Cancer, Stage IRecruiting
Est. primary completion 2026-12-16 · NCT06254911 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C MutationActive not recruiting
Est. primary completion 2026-12-17 · NCT04185883 · CT.gov ↗
What to watch
Phase 2Breast Cancer, Triple Negative Breast Cancer, Residual Cancer, Circulating Tumor DNARecruiting
Est. primary completion 2026-12-30 · NCT04434040 · CT.gov ↗
What to watch
Phase 2Sarcoma,Soft TissueActive not recruiting
Est. primary completion 2026-12-30 · NCT03474094 · CT.gov ↗
What to watch
Phase 1Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05488522 · CT.gov ↗
What to watch
Phase 2Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2026-12-31 · NCT05340309 · CT.gov ↗
What to watch
Phase 2Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 …Active not recruiting
Est. primary completion 2026-12-31 · NCT03784326 · CT.gov ↗
What to watch
Phase 3CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT03148418 · CT.gov ↗
What to watch
2027 (99)
January 2027 (9)
Phase 1Extensive-stage Small-cell Lung CancerRecruiting
Est. primary completion 2027-01 · NCT06807632 · CT.gov ↗
What to watch
Phase 1/2Solid Tumor, RhabdomyosarcomaRecruiting
Est. primary completion 2027-01 · NCT04796012 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-01-01 · NCT04467723 · CT.gov ↗
What to watch
Phase 2Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2027-01-01 · NCT06731270 · CT.gov ↗
What to watch
Phase 2Hepato Cellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-01-01 · NCT07276100 · CT.gov ↗
What to watch
Phase 1/2Advanced Malignant Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-01-03 · NCT03830918 · CT.gov ↗
What to watch
Phase 1Extensive Stage Lung Small Cell CarcinomaActive not recruiting
Est. primary completion 2027-01-27 · NCT04560972 · CT.gov ↗
What to watch
Phase 1Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-01-31 · NCT05096715 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-01-31 · NCT06066138 · CT.gov ↗
What to watch
February 2027 (5)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT06463665 · CT.gov ↗
What to watch
Phase 2Bladder CancerActive not recruiting
Est. primary completion 2027-02 · NCT04186013 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-02 · NCT05798663 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-02-01 · NCT05440708 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia …Active not recruiting
Est. primary completion 2027-02-28 · NCT02846623 · CT.gov ↗
What to watch
March 2027 (8)
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-03 · NCT05516628 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Liver Neoplasms, Carcinoma, HepatocellularRecruiting
Est. primary completion 2027-03 · NCT07246668 · CT.gov ↗
What to watch
Phase 2/3Colorectal NeoplasmsActive not recruiting
Est. primary completion 2027-03 · NCT05141721 · CT.gov ↗
What to watch
Phase 1Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid TumorsActive not recruiting
Est. primary completion 2027-03-03 · NCT06031441 · CT.gov ↗
What to watch
Phase 1Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin NeoplasmActive not recruiting
Est. primary completion 2027-03-31 · NCT04387084 · CT.gov ↗
What to watch
Phase 1Small Cell Lung Carcinoma (SCLC)Active not recruiting
Est. primary completion 2027-03-31 · NCT06077500 · CT.gov ↗
What to watch
Phase 2Small Cell Carcinoma of LungRecruiting
Est. primary completion 2027-03-31 · NCT06830694 · CT.gov ↗
What to watch
Phase 3Breast CancerActive not recruiting
Est. primary completion 2027-03-31 · NCT04873362 · CT.gov ↗
What to watch
April 2027 (5)
Phase 2Colorectal CancerActive not recruiting
Est. primary completion 2027-04 · NCT05118724 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2027-04-06 · NCT05434234 · CT.gov ↗
What to watch
Early phase / not applicableAdvanced Hepatocellular Carcinoma, Chemotherapy, Stereotactic Body RadiotherapyRecruiting
Est. primary completion 2027-04-25 · NCT06595108 · CT.gov ↗
What to watch
Phase 2Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate CancerRecruiting
Est. primary completion 2027-04-30 · NCT03821246 · CT.gov ↗
What to watch
Phase 4Hepatocellular Carcinoma, Hepatocellular CancerRecruiting
Est. primary completion 2027-04-30 · NCT05185505 · CT.gov ↗
What to watch
May 2027 (6)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-05 · NCT03896074 · CT.gov ↗
What to watch
Phase 2Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma …Recruiting
Est. primary completion 2027-05-01 · NCT05333458 · CT.gov ↗
What to watch
Phase 1Cancer-NeoplasmsActive not recruiting
Est. primary completion 2027-05-12 · NCT06537310 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, Gastroesophageal Junction AdenocarcinomaActive not recruiting
Est. primary completion 2027-05-31 · NCT03421288 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2027-05-31 · NCT04721132 · CT.gov ↗
What to watch
June 2027 (15)
Phase 1Osteosarcoma, Pulmonary Recurrence of OsteosarcomaRecruiting
Est. primary completion 2027-06 · NCT06492954 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma of the Anal CanalRecruiting
Est. primary completion 2027-06 · NCT05661188 · CT.gov ↗
What to watch
Phase 2Prostate CancerRecruiting
Est. primary completion 2027-06-01 · NCT04812366 · CT.gov ↗
What to watch
Phase 2Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-06-01 · NCT04310020 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06-01 · NCT05317858 · CT.gov ↗
What to watch
Phase 3Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8Active not recruiting
Est. primary completion 2027-06-01 · NCT03775265 · CT.gov ↗
What to watch
Phase 3Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7Active not recruiting
Est. primary completion 2027-06-01 · NCT02997228 · CT.gov ↗
What to watch
Phase 1Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma …Active not recruiting
Est. primary completion 2027-06-14 · NCT05334329 · CT.gov ↗
What to watch
Phase 1Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma …Active not recruiting
Est. primary completion 2027-06-30 · NCT03321643 · CT.gov ↗
What to watch
Phase 1/2Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesActive not recruiting
Est. primary completion 2027-06-30 · NCT02935361 · CT.gov ↗
What to watch
Phase 1/2Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung CancerRecruiting
Est. primary completion 2027-06-30 · NCT06110572 · CT.gov ↗
What to watch
Phase 2Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma …Active not recruiting
Est. primary completion 2027-06-30 · NCT03237780 · CT.gov ↗
What to watch
Phase 2Neoplasm MetastasisActive not recruiting
Est. primary completion 2027-06-30 · NCT00781612 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT03178552 · CT.gov ↗
What to watch
Phase 3NeoplasmsActive not recruiting
Est. primary completion 2027-06-30 · NCT05112965 · CT.gov ↗
What to watch
July 2027 (16)
Phase 1SCLC,Extensive StageActive not recruiting
Est. primary completion 2027-07 · NCT05595460 · CT.gov ↗
What to watch
Phase 3Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-07 · NCT04803994 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-07-01 · NCT06097962 · CT.gov ↗
What to watch
Phase 2CancerActive not recruiting
Est. primary completion 2027-07-01 · NCT06754501 · CT.gov ↗
What to watch
Phase 2Extensive Stage Lung Small Cell CarcinomaRecruiting
Est. primary completion 2027-07-01 · NCT04696575 · CT.gov ↗
What to watch
Phase 2Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8Active not recruiting
Est. primary completion 2027-07-01 · NCT05411081 · CT.gov ↗
What to watch
Phase 1/2Extensive Stage-small Cell Lung CancerRecruiting
Est. primary completion 2027-07-20 · NCT06362252 · CT.gov ↗
What to watch
Phase 1PIK3CA-Mutated CancersActive not recruiting
Est. primary completion 2027-07-21 · NCT06496568 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumor, LymphomaActive not recruiting
Est. primary completion 2027-07-30 · NCT05878691 · CT.gov ↗
What to watch
Phase 1/2Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic …Active not recruiting
Est. primary completion 2027-07-30 · NCT07280377 · CT.gov ↗
What to watch
Phase 1/2Advanced Liver CancersActive not recruiting
Est. primary completion 2027-07-30 · NCT04524871 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-07-30 · NCT06096779 · CT.gov ↗
What to watch
Phase 3Mesotheliomas PleuralRecruiting
Est. primary completion 2027-07-30 · NCT04996017 · CT.gov ↗
What to watch
Phase 2Cancer, Carcinoma, Squamous Cell Carcinoma, Head and Neck CancerActive not recruiting
Est. primary completion 2027-07-31 · NCT03708224 · CT.gov ↗
What to watch
Phase 2Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2027-07-31 · NCT03181100 · CT.gov ↗
What to watch
August 2027 (5)
Phase 1Glioblastoma MultiformeRecruiting
Est. primary completion 2027-08 · NCT05423210 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-08 · NCT06695026 · CT.gov ↗
What to watch
Phase 2Peritoneal Malignant MesotheliomaRecruiting
Est. primary completion 2027-08-01 · NCT05001880 · CT.gov ↗
What to watch
Phase 4Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-08-01 · NCT07059494 · CT.gov ↗
What to watch
Phase 3Venous ThrombosisActive not recruiting
Est. primary completion 2027-08-31 · NCT04649489 · CT.gov ↗
What to watch
September 2027 (6)
Phase 2Cancer, Tumors, Neoplasm, NeoplasiaRecruiting
Est. primary completion 2027-09 · NCT02925234 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2027-09-01 · NCT07774247 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-09-01 · NCT04253964 · CT.gov ↗
What to watch
Phase 1Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-09-10 · NCT05085496 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-09-30 · NCT06444815 · CT.gov ↗
What to watch
Phase 2Appendix Adenocarcinoma, Human Papillomavirus-Related Anal Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2027-09-30 · NCT03074513 · CT.gov ↗
What to watch
October 2027 (6)
Phase 1/2Malignant Pleural MesotheliomaRecruiting
Est. primary completion 2027-10 · NCT05765084 · CT.gov ↗
What to watch
Phase 2Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma BladderRecruiting
Est. primary completion 2027-10 · NCT05312671 · CT.gov ↗
What to watch
Phase 2Metastatic Cancer, Melanoma Cancer, Lung Cancer, Bladder Cancer, Renal Cancer, Head/Neck CancersActive not recruiting
Est. primary completion 2027-10 · NCT03693014 · CT.gov ↗
What to watch
Phase 2Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST) …Recruiting
Est. primary completion 2027-10 · NCT05152472 · CT.gov ↗
What to watch
Phase 2Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Genitourinary Cancer, Gynecologic Cancer, Sarcoma, Unknown Primary Tumors …Recruiting
Est. primary completion 2027-10 · NCT04273061 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2027-10-31 · NCT05907980 · CT.gov ↗
What to watch
November 2027 (3)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-11 · NCT06332755 · CT.gov ↗
What to watch
Phase 2Small Cell Carcinoma of the Bladder, Small Cell Carcinoma of the Urinary Tract, Squamous Cell Carcinoma of the Bladder …Recruiting
Est. primary completion 2027-11-01 · NCT06161532 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular Carcinoma With High Risk of RecurrenceRecruiting
Est. primary completion 2027-11-10 · NCT07239245 · CT.gov ↗
What to watch
December 2027 (15)
Phase 1/2Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) …Recruiting
Est. primary completion 2027-12 · NCT05652686 · CT.gov ↗
What to watch
Phase 1/2Small Cell Lung Cancer Extensive StageRecruiting
Est. primary completion 2027-12 · NCT05703971 · CT.gov ↗
What to watch
Phase 2Extensive Stage Lung Small Cell CancerNot yet recruiting
Est. primary completion 2027-12 · NCT07172412 · CT.gov ↗
What to watch
Phase 2Extensive-stage Small-cell Lung CancerRecruiting
Est. primary completion 2027-12 · NCT07654400 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Biliary Tract CancerRecruiting
Est. primary completion 2027-12-01 · NCT05733598 · CT.gov ↗
What to watch
Phase 2/3Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2027-12-15 · NCT05063552 · CT.gov ↗
What to watch
Phase 2Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma …Recruiting
Est. primary completion 2027-12-30 · NCT04919382 · CT.gov ↗
What to watch
Phase 1Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT06478693 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT04449874 · CT.gov ↗
What to watch
Phase 1/2Recurrent Glioblastoma, Recurrent GliosarcomaActive not recruiting
Est. primary completion 2027-12-31 · NCT05039281 · CT.gov ↗
What to watch
Phase 2Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory CarcinomaActive not recruiting
Est. primary completion 2027-12-31 · NCT03202316 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Locally Advanced Osteosarcoma, Metastatic Osteosarcoma, Recurrent Osteosarcoma, Refractory Osteosarcoma, Unresectable OsteosarcomaRecruiting
Est. primary completion 2027-12-31 · NCT05019703 · CT.gov ↗
What to watch
Phase 2Hereditary Leiomyomatosis and Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma …Recruiting
Est. primary completion 2027-12-31 · NCT04981509 · CT.gov ↗
What to watch
Phase 2Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid TumorsRecruiting
Est. primary completion 2027-12-31 · NCT02693535 · CT.gov ↗
What to watch
2028 (41)
January 2028 (8)
Phase 1/2Solid CancerActive not recruiting
Est. primary completion 2028-01-01 · NCT06771622 · CT.gov ↗
What to watch
Phase 2Recurrent GlioblastomaRecruiting
Est. primary completion 2028-01-01 · NCT06069726 · CT.gov ↗
What to watch
Phase 2Soft Tissue SarcomaRecruiting
Est. primary completion 2028-01-01 · NCT07049848 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Richter's TransformationRecruiting
Est. primary completion 2028-01-15 · NCT06043674 · CT.gov ↗
What to watch
Phase 1/2Small-Cell Lung Cancer, Neuroendocrine CarcinomaActive not recruiting
Est. primary completion 2028-01-28 · NCT04471727 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-01-30 · NCT06294548 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-01-31 · NCT02525757 · CT.gov ↗
What to watch
Phase 2Large Cell Neuroendocrine Carcinoma of the LungActive not recruiting
Est. primary completion 2028-01-31 · NCT05470595 · CT.gov ↗
What to watch
February 2028 (4)
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2028-02 · NCT04727307 · CT.gov ↗
What to watch
Phase 1Endometrial Cancer, Metastasis, Endometrioid Endometrial Cancer, Carcinosarcoma, Serous Adenocarcinoma of Endometrium (Diagnosis) …Recruiting
Est. primary completion 2028-02-21 · NCT05542407 · CT.gov ↗
What to watch
Phase 1/2Advanced Cholangiocarcinoma, FGFR2 FusionRecruiting
Est. primary completion 2028-02-22 · NCT06439485 · CT.gov ↗
What to watch
Phase 2Ovarian CancerActive not recruiting
Est. primary completion 2028-02-28 · NCT04931342 · CT.gov ↗
What to watch
March 2028 (4)
Phase 2Immunotherapy, HCC - Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-03 · NCT05690048 · CT.gov ↗
What to watch
Phase 1/2Extensive Stage Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-03-07 · NCT05142696 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-03-27 · NCT05528952 · CT.gov ↗
What to watch
Phase 2Glioblastoma, Recurrence TumorRecruiting
Est. primary completion 2028-03-30 · NCT07263438 · CT.gov ↗
What to watch
April 2028 (1)
Phase 3Colorectal CancerRecruiting
Est. primary completion 2028-04-01 · NCT06733038 · CT.gov ↗
What to watch
June 2028 (1)
Phase 2BRAF V600 Wild Type, Clinical Stage IV Cutaneous Melanoma AJCC v8, Intracranial Melanoma, Metastatic Malignant Neoplasm in the Brain …Active not recruiting
Est. primary completion 2028-06-30 · NCT03175432 · CT.gov ↗
What to watch
July 2028 (4)
Phase 1Metastatic Microsatellite-stable Colorectal CancerRecruiting
Est. primary completion 2028-07 · NCT06012734 · CT.gov ↗
What to watch
Phase 4Oncology, Infusion ReactionRecruiting
Est. primary completion 2028-07 · NCT06031233 · CT.gov ↗
What to watch
Phase 3CancerActive not recruiting
Est. primary completion 2028-07-05 · NCT03768063 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-07-31 · NCT05581004 · CT.gov ↗
What to watch
August 2028 (3)
Early phase / not applicableHepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor ThrombusRecruiting
Est. primary completion 2028-08-01 · NCT05984511 · CT.gov ↗
What to watch
Phase 2Extensive Stage Small Cell Lung Cancer (ES-SCLC)Recruiting
Est. primary completion 2028-08-30 · NCT06663098 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma, Atezolizumab Plus Bevacizumab, Transarterial ChemoembolizationNot yet recruiting
Est. primary completion 2028-08-31 · NCT07543510 · CT.gov ↗
What to watch
September 2028 (3)
Phase 3Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)Recruiting
Est. primary completion 2028-09-09 · NCT07472517 · CT.gov ↗
What to watch
Phase 1Advanced Solid MalignanciesActive not recruiting
Est. primary completion 2028-09-15 · NCT06760481 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma Non-resectableRecruiting
Est. primary completion 2028-09-30 · NCT06133062 · CT.gov ↗
What to watch
October 2028 (3)
Phase 2Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer MetastaticActive not recruiting
Est. primary completion 2028-10 · NCT03614949 · CT.gov ↗
What to watch
Phase 2/3Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma …Recruiting
Est. primary completion 2028-10-01 · NCT05058651 · CT.gov ↗
What to watch
November 2028 (1)
Phase 1/2Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaRecruiting
Est. primary completion 2028-11 · NCT07407933 · CT.gov ↗
What to watch
December 2028 (9)
Phase 1Treatment-Refractory Solid TumorsNot yet recruiting
Est. primary completion 2028-12 · NCT07170592 · CT.gov ↗
What to watch
Phase 1Treatment-Refractory Solid TumorsRecruiting
Est. primary completion 2028-12 · NCT07190833 · CT.gov ↗
What to watch
Phase 3Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2028-12 · NCT06680258 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-12-05 · NCT07317414 · CT.gov ↗
What to watch
Phase 3Extensive-stage Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-16 · NCT06719336 · CT.gov ↗
What to watch
Phase 1/2Metastatic MalignancyRecruiting
Est. primary completion 2028-12-31 · NCT05394337 · CT.gov ↗
What to watch
Phase 1/2Neoplasms, Prostatic Neoplasms, Castration-Resistant, Stomach Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms …Recruiting
Est. primary completion 2028-12-31 · NCT05944237 · CT.gov ↗
What to watch
Phase 2Rectal CancerActive not recruiting
Est. primary completion 2028-12-31 · NCT04017455 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma, Transarterial ChemoembolizationNot yet recruiting
Est. primary completion 2028-12-31 · NCT07281664 · CT.gov ↗
What to watch
2029 (16)
February 2029 (2)
March 2029 (3)
Phase 3Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8Recruiting
Est. primary completion 2029-03-10 · NCT07166406 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2029-03-30 · NCT06339424 · CT.gov ↗
What to watch
Phase 2Carcinoma, HepatocellularRecruiting
Est. primary completion 2029-03-31 · NCT07010497 · CT.gov ↗
What to watch
April 2029 (3)
Phase 2Small Cell Lung CancerRecruiting
Est. primary completion 2029-04 · NCT07155174 · CT.gov ↗
What to watch
Phase 2Cancer, Tumors, Neoplasms, NeoplasiaRecruiting
Est. primary completion 2029-04-30 · NCT04341181 · CT.gov ↗
What to watch
Phase 3Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2029-04-30 · NCT06632327 · CT.gov ↗
What to watch
May 2029 (1)
Phase 1/2Inoperable, Locally Advanced or Metastatic, ER-positive Breast CancerRecruiting
Est. primary completion 2029-05-30 · NCT04802759 · CT.gov ↗
What to watch
June 2029 (2)
July 2029 (1)
Phase 1/2Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2029-07-25 · NCT06287775 · CT.gov ↗
What to watch
August 2029 (1)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2029-08-31 · NCT03228667 · CT.gov ↗
What to watch
September 2029 (1)
Phase 1Small-cell Lung Cancer, Small Cell Lung Cancer Extensive StageRecruiting
Est. primary completion 2029-09-30 · NCT07545954 · CT.gov ↗
What to watch
October 2029 (2)
Phase 2/3Malignancy, Malignant Neoplasm, Lymphoproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, Cancer …Recruiting
Est. primary completion 2029-10 · NCT05770102 · CT.gov ↗
What to watch
Phase 2/3Haematological Malignancy, Solid TumourRecruiting
Est. primary completion 2029-10 · NCT05722886 · CT.gov ↗
What to watch
2030 (13)
January 2030 (3)
Phase 1Extensive Stage Small Cell Lung Cancer (ES-SCLC)Recruiting
Est. primary completion 2030-01 · NCT07113691 · CT.gov ↗
What to watch
Phase 3Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung Cancer …Recruiting
Est. primary completion 2030-01 · NCT07625644 · CT.gov ↗
What to watch
Phase 2Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic TreatmentRecruiting
Est. primary completion 2030-01-01 · NCT06254248 · CT.gov ↗
What to watch
March 2030 (2)
Phase 2Early-stage Breast CancerRecruiting
Est. primary completion 2030-03 · NCT05332561 · CT.gov ↗
What to watch
Phase 1/2Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma, Malignant Solid Neoplasm …Active not recruiting
Est. primary completion 2030-03-31 · NCT05286801 · CT.gov ↗
What to watch
April 2030 (1)
Phase 1/2Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology …Not yet recruiting
Est. primary completion 2030-04-26 · NCT07707895 · CT.gov ↗
What to watch
May 2030 (3)
Phase 1Extensive Stage Small Cell Lung CancerActive not recruiting
Est. primary completion 2030-05-30 · NCT05361395 · CT.gov ↗
What to watch
Phase 1/2Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8 …Recruiting
Est. primary completion 2030-05-31 · NCT03942328 · CT.gov ↗
What to watch
Phase 3Cancer, Renal Cell Carcinoma (RCC), Pancreatic Neuroendocrine Tumors (pNET), Extra-Pancreatic NET (epNET), Hepatocellular Carcinoma (HCC) …Enrolling by invitation
Est. primary completion 2030-05-31 · NCT07620574 · CT.gov ↗
What to watch
August 2030 (1)
Phase 1Metastatic Colorectal CancerRecruiting
Est. primary completion 2030-08-31 · NCT04929223 · CT.gov ↗
What to watch
September 2030 (1)
Phase 1/2Metastatic Breast CancerRecruiting
Est. primary completion 2030-09-30 · NCT03424005 · CT.gov ↗
What to watch
November 2030 (2)
Phase 2Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma …Recruiting
Est. primary completion 2030-11-01 · NCT07322341 · CT.gov ↗
What to watch
Phase 1/2Small Cell Lung Cancer Extensive StageRecruiting
Est. primary completion 2030-11-29 · NCT07227597 · CT.gov ↗
What to watch
2031 (4)
January 2031 (1)
Phase 2Adenocarcinoma, Pancreatic DuctalActive not recruiting
Est. primary completion 2031-01-01 · NCT05968326 · CT.gov ↗
What to watch
June 2031 (2)
Phase 1/2Hepatocellular Carcinoma (HCC), Macrovascular Invasion, Liver Transplant Surgery, DownstagingRecruiting
Est. primary completion 2031-06 · NCT06725121 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2031-06 · NCT07018947 · CT.gov ↗
What to watch
August 2031 (1)
Phase 2Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor, Hedgehog InhibitorRecruiting
Est. primary completion 2031-08-30 · NCT05538091 · CT.gov ↗
What to watch
2032 (3)
June 2032 (1)
Phase 1/2Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor, Pediatric Cancer, Pediatric Solid Tumor, Fibrolamellar CarcinomaRecruiting
Est. primary completion 2032-06 · NCT05468359 · CT.gov ↗
What to watch
2033 (1)
March 2033 (1)
2034 (1)
March 2034 (1)
Phase 2/3Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2034-03-31 · NCT07293468 · CT.gov ↗
What to watch
2035 (1)
May 2035 (1)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2035-05-02 · NCT07153445 · CT.gov ↗
What to watch
2040 (3)
February 2040 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2040-02-28 · NCT07770100 · CT.gov ↗
What to watch
March 2040 (1)
Phase 2Cancer MetastaticRecruiting
Est. primary completion 2040-03-30 · NCT04817956 · CT.gov ↗
What to watch
July 2040 (1)
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2040-07-01 · NCT05620771 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.